Arcutis Biotherapeutics reported a Schedule 13G filing showing State Street Corporation beneficially owns 6,296,197 shares of Common Stock. The filing states this equals 5.1% of the class and lists 03/31/2026 as the reporting date. The filing attributes shared voting power of 5,996,079 and shared dispositive power of 6,296,197 to State Street and names several State Street advisory subsidiaries in Item 7.
Positive
None.
Negative
None.
Insights
Large passive holding disclosed: State Street reports a 5.1% beneficial stake.
State Street Corporation reports beneficial ownership of 6,296,197 shares of Arcutis Common Stock with shared voting power of 5,996,079. The filing lists specific State Street advisory subsidiaries under Item 7, indicating ownership on behalf of multiple advisory entities.
Timing is tied to 03/31/2026. Cash‑flow treatment and specific trading intent are not included in the excerpt; subsequent disclosures could show transaction activity by these advisory accounts.
Schedule 13G indicates passive investor reporting rather than an active activist position.
The Schedule 13G format and Item 6 statement 'NOT APPLICABLE' for others having dividend/proceeds rights are consistent with institutional passive reporting. Multiple State Street entities are identified in Item 7 as investment-advisor filers.
Filing is signed by a corporate officer on 05/12/2026, which aligns with routine Section 13 reporting timelines.
Key Figures
Beneficially owned:6,296,197 sharesPercent of class:5.1%Shared voting power:5,996,079 shares
3 metrics
Beneficially owned6,296,197 sharesAmount beneficially owned reported in Item 4
Percent of class5.1%Percent of class reported in Item 4
Shared voting power5,996,079 sharesShared power to vote reported in Item 4
Key Terms
Schedule 13G, Beneficially owned, Shared dispositive power
3 terms
Schedule 13Gregulatory
"Item 1(a) and filing header showing the form type"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficially ownedfinancial
"Item 4: 'Amount beneficially owned: 6296197.00'"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared dispositive powerregulatory
"Item 4: '(iv) Shared power to dispose or to direct the disposition of: 6,296,197'"
State Street Corporation filed the Schedule 13G. The filing lists the filer as State Street Corporation with principal office at One Congress Street, Suite 1, Boston, MA, and identifies State Street advisory subsidiaries under Item 7.
How many ARQT shares does State Street beneficially own?
The filing reports State Street beneficially owns 6,296,197 shares of Common Stock. The filing also reports shared voting power of 5,996,079 and states ownership equals 5.1% of the class.
What date and signature appear on the filing?
The Schedule 13G references 03/31/2026 as the reporting date and is signed by Elizabeth Schaefer, titled Senior Vice President, Chief Accounting Officer, with a signature date of 05/12/2026.
Does the filing identify who directs voting or disposition?
Yes. The filing lists 0 shares with sole voting or dispositive power, 5,996,079 shares with shared voting power, and 6,296,197 shares with shared dispositive power, per Item 4 of the form.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
ARCUTIS BIOTHERAPEUTICS INC
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
03969K108
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
03969K108
1
Names of Reporting Persons
STATE STREET CORPORATION
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
MASSACHUSETTS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,996,079.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,296,197.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,296,197.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.1 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
ARCUTIS BIOTHERAPEUTICS INC
(b)
Address of issuer's principal executive offices:
2945 TOWNSGATE ROAD SUITE 110, WESTLAKE VILLAGE, CALIFORNIA, 91361
Item 2.
(a)
Name of person filing:
STATE STREET CORPORATION;
(b)
Address or principal business office or, if none, residence:
ONE CONGRESS STREET, SUITE 1, BOSTON MA 02114, UNITED STATES
(c)
Citizenship:
MA
(d)
Title of class of securities:
COMMON STOCK
(e)
CUSIP Number(s):
03969K108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
6296197.00
(b)
Percent of class:
5.1 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
5,996,079
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
6,296,197
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
NOT APPLICABLE
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
SSGA FUNDS MANAGEMENT, INC. (IA);STATE STREET GLOBAL ADVISORS EUROPE LIMITED (IA);STATE STREET GLOBAL ADVISORS LIMITED (IA);STATE STREET GLOBAL ADVISORS TRUST COMPANY (IA);STATE STREET GLOBAL ADVISORS, LTD. (IA);
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
NOT APPLICABLE
Item 9.
Notice of Dissolution of Group.
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
NOT APPLICABLE
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
